Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells

Journal of Innate Immunity

Volumn 8, Issue 4, 2016, Pages 374-385

  Djaoud, Zakia ^a,b   Riou, Raphaëlle ^a,b   Gavlovsky, Pierre Jean ^d   Mehlal, Souad ^b   Bressollette, Céline ^b,e,f   Gérard, Nathalie ^d   Gagne, Katia ^a,b,g   Charreau, Béatrice ^c,d,e   Retière, Christelle ^a,b  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Laboratoire d'Acoustique Environnementale   (France)

^d INSERM   (France)

^e Institut de Transplantation Urologie Néphrologie ITUN   (France)

^f NANTES UNIVERSITY HOSPITAL   (France)

^g UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cytomegalovirus; Endothelial cells; Human leukocyte antigen E; Natural killer cells; NKG2C

Indexed keywords

HLA ANTIGEN CLASS 1; HLA E ANTIGEN; HLA-E ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KIR2DL1 PROTEIN, HUMAN; KLRC2 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C;

ALLELE; ANTIGEN EXPRESSION; AORTA; ARTICLE; BINDING AFFINITY; CARDIAC MUSCLE CELL; CELL ACTIVATION; CELL EXPANSION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEGRANULATION; DOWN REGULATION; ENDOTHELIUM CELL; EX VIVO STUDY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KIDNEY GRAFT; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; CELL CULTURE; CELL PROLIFERATION; CYTOMEGALOVIRUS; DENDRITIC CELL; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; METABOLISM; PATHOLOGY; VASCULAR ENDOTHELIUM; VIROLOGY;

AORTA; CELL DEGRANULATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DENDRITIC CELLS; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC MEMORY; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; RECEPTORS, KIR2DL1;

EID: 84973904893     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000445320     Document Type: Article

References (40)

1. Biron CA, Byron KS, Sullivan JL: Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989; 320: 1731-1735.
2. Orange JS: Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect Inst Pasteur 2002; 4: 1545-1558.
3. Sansoni P, Vescovini R, Fagnoni FF, Akbar A, Arens R, Chiu Y-L, et al: New advances in CMV and immunosenescence. Exp Gerontol 2014; 55: 54-62.
4. Wilkinson GWG, Tomasec P, Stanton RJ, Armstrong M, Prod'homme V, Aicheler R, et al: Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 2008; 41: 206-212.
5. Beck S, Barrell BG: Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 1988; 331: 269-272.
6. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, et al: HLA-E binds to natural killer cell receptors CD94/ NKG2A, B and C. Nature 1998; 391: 795-799.
7. Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, et al: Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000; 287: 1031.
8. Chalupny NJ, Rein-Weston A, Dosch S, Cosman D: Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun 2006; 346: 175-181.
9. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, et al: ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001; 14: 123-133.
10. Fielding CA, Aicheler R, Stanton RJ, Wang ECY, Han S, Seirafian S, et al: Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLoS Pathog 2014; 10:e1004058.
11. Nachmani D, Lankry D, Wolf DG, Mandelboim O: The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination. Nat Immunol 2010; 11: 806-813.
12. Nachmani D, Gutschner T, Reches A, Diederichs S, Mandelboim O: RNA-binding proteins regulate the expression of the immune activating ligand MICB. Nat Commun 2014; 5: 4186.
13. Beziat V, Liu LL, Malmberg J-A, Ivarsson MA, Sohlberg E, Bjorklund AT, et al: NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013; 121: 2678-2688.
14. Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M: Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004; 104: 3664-3671.
15. Guma M, Budt M, Saez A, Brckalo T, Hengel H, Angulo A, et al: Expansion of CD94/ NKG2C + NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006; 107: 3624-3631.
16. Lopez-Verges S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, et al: Expansion of a unique CD57 + NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci USA 2011; 108: 14725-14732.
17. Lanier LL, Corliss B, Wu J, Phillips JH: Association of DAP12 with activating CD94/ NKG2C NK cell receptors. Immunity 1998; 8: 693-701.
18. Djaoud Z, David G, Bressollette C, Willem C, Rettman P, Gagne K, et al: Amplified NKG2C + NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Iglike receptor 2DL: functional impact in controlling CMV-infected dendritic cells. J Immunol 2013; 191: 2708-2716.
19. Rolle A, Pollmann J, Ewen E-M, Le VTK, Halenius A, Hengel H, et al: IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C + NK cell expansion. J Clin Invest 2014; 124: 5305-5316.
20. Jarvis MA, Nelson JA: Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal. J Virol 2007; 81: 2095-2101.
21. Coupel S, Leboeuf F, Boulday G, Soulillou J-P, Charreau B: RhoA activation mediates phosphatidylinositol 3-kinase-dependent proliferation of human vascular endothelial cells: an alloimmune mechanism of chronic allograft nephropathy. J Am Soc Nephrol 2004; 15: 2429-2439.
22. Tonnerre P, Gerard N, Chatelais M, Poli C, Allard S, Cury S, et al: MICA variant promotes allosensitization after kidney transplantation. J Am Soc Nephrol 2013; 24: 954-966.
23. Repnik U, Knezevic M, Jeras M: Simple and cost-effective isolation of monocytes from buffy coats. J Immunol Methods 2003; 278: 283-292.
24. Garrett JS, Narus JC, Bohnsack JF, Carling DE, Grieves KG, Waldman WJ, et al: Effects of cytomegalovirus infection on growth factor production in endothelial cells and fibroblasts. Pediatr Res 1995; 38: 1003-1008.
25. David G, Morvan M, Gagne K, Kerdudou N, Willem C, Devys A, et al: Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies. Immunology 2009; 128: 172-184.
26. Navenot JM, Merghoub T, Ducrocq R, Muller JY, Krishnamoorthy R, Blanchard D: New method for quantitative determination of fetal hemoglobin-containing red blood cells by flow cytometry: application to sickle-cell disease. Cytometry 1998; 32: 186-190.
27. Heatley SL, Pietra G, Lin J, Widjaja JML, Harpur CM, Lester S, et al: Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells. J Biol Chem 2013; 288: 8679-8690.
28. Beziat V, Dalgard O, Asselah T, Halfon P, Bedossa P, Boudifa A, et al: CMV drives clonal expansion of NKG2C + NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol 2012; 42: 447-457.
29. Robinson J, Halliwell JA, McWilliam H, Lopez R, Parham P, Marsh SGE: The IMGT/ HLA database. Nucleic Acids Res 2013; 41: D1222-D1227.
30. Strong RK, Holmes MA, Li P, Braun L, Lee N, Geraghty DE: HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem 2003; 278: 5082-5090.
31. Lauterbach N, Wieten L, Popeijus HE, Vanderlocht J, van Zon PMH, Voorter CEM, et al: Peptide-induced HLA-E expression in human PBMCs is dependent on peptide sequence and the HLA-E genotype. Tissue Antigens 2015; 85: 242-251.
32. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR: Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011; 39:D913-D919.
33. Moutaftsi M, Mehl AM, Borysiewicz LK, Tabi Z: Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 2002; 99: 2913-2921.
34. Odeberg J, Cerboni C, Browne H, Karre K, Moller E, Carbone E, et al: Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand J Immunol 2002; 55: 149-161.
35. Nachmani D, Zimmermann A, Oiknine Djian E, Weisblum Y, Livneh Y, Khanh Le VT, et al: MicroRNA editing facilitates immune elimination of HCMV infected cells. PLoS Pathog 2014; 10:e1003963.
36. Wang ECY, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK, et al: UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc Natl Acad Sci USA 2002; 99: 7570-7575.
37. Guma M, Cabrera C, Erkizia I, Bofill M, Clotet B, Ruiz L, et al: Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/ NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis 2006; 194: 38-41.
38. Kahl M, Siegel-Axel D, Stenglein S, Jahn G, Sinzger C: Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J Virol 2000; 74: 7628-7635.
39. O'Sullivan TE, Sun JC: Generation of natural killer cell memory during viral infection. J Innate Immun 2015; 7: 557-562.
40. Ricotta D, Alessandri G, Pollara C, Fiorentini S, Favilli F, Tosetti M, et al: Adult human heart microvascular endothelial cells are permissive for non-lytic infection by human cytomegalovirus. Cardiovasc Res 2001; 49: 440-448.